Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Presenter: Manel Sabate

October 24, 2023

News Features

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

Shelley Wood

May 08, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Conference News TCT 2021

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

L.A. McKeown

October 25, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

News Conference News TCT 2020

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

L.A. McKeown

October 22, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

Advertisement

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

FDA Approves Bioresorbable Scaffold for BTK Lesions

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Top Endovascular News of 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Some Rays of Hope for ‘Sorry State’ of Transplant Rejection

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Top Endovascular News of 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content